Aberdeen Asset Management’s AbbVie ABBV Stock Holding History

Aberdeen Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$61.6M	Buy	848,944 +7,840	+0.9%	+$527K	0.21%	83
2017 Q1	$54.8M	Buy	841,104 +27,151	+3%	+$1.71M	0.19%	88
2016 Q4	$51M	Buy	813,953 +59,003	+8%	+$3.6M	0.19%	91
2016 Q3	$47.6M	Buy	754,950 +13,045	+2%	+$844K	0.17%	81
2016 Q2	$45.9M	Buy	741,905 +45,909	+7%	+$2.8M	0.17%	84
2016 Q1	$39.8M	Buy	695,996 +2,359	+0.3%	+$131K	0.14%	95
2015 Q4	$33.5M	Buy	693,637 +45,893	+7%	+$2.64M	0.11%	122
2015 Q3	$35.2M	Sell	647,744 -38,075	-6%	-$2.48M	0.12%	105
2015 Q2	$46.1M	Sell	685,819 -135,859	-17%	-$8.87M	0.13%	91
2015 Q1	$48.1M	Sell	821,678 -43,063	-5%	-$2.6M	0.13%	91
2014 Q4	$56.6M	Sell	864,741 -73,701	-8%	-$4.65M	0.14%	84
2014 Q3	$54.2M	Sell	938,442 -34,894	-4%	-$1.94M	0.12%	99
2014 Q2	$54.9M	Buy	973,336 +807,168	+486%	+$42.3M	0.11%	107
2014 Q1	$8.54M	Sell	166,168 -600	-0.4%	-$30.3K	0.02%	136
2013 Q4	$8.74M	Hold	166,768	–	–	0.02%	135
2013 Q3	$7.46M	Sell	166,768 -14,160	-8%	-$628K	0.02%	136
2013 Q2	$7.48M	Buy	+180,928	New	+$7.91M	0.02%	137

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aberdeen Asset Management's ABBV Position: Q2 2017 in Review

Aberdeen Asset Management increased its AbbVie (ABBV) stake by 0.93% in Q2 2017, buying an estimated $527K and bringing the position to 848,944 shares worth $61.6M. The position accounts for 0.21% of the portfolio, ranked #83.

Aberdeen Asset Management first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

Aberdeen Asset Management held 848,944 shares of AbbVie worth $61.6M as of Q2 2017.
Aberdeen Asset Management bought 7,840 AbbVie shares in Q2 2017, an estimated $527K.
AbbVie made up 0.21% of Aberdeen Asset Management's portfolio in Q2 2017, its #83 holding.
Aberdeen Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.